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Background: Sizing of GGGGCC hexanucleotide repeat expansions within the C9ORF72 locus, which account for
approximately 10% of all amyotrophic lateral sclerosis (ALS) cases, is urgently required to answer fundamental
questions about mechanisms of pathogenesis in this important genetic variant. Currently employed PCR protocols
are limited to discrimination between the presence and absence of a modified allele with more than 30 copies of
the repeat, while Southern hybridisation-based methods are confounded by the somatic heterogeneity commonly
present in blood samples, which might cause false-negative or ambiguous results.
Results: We describe an optimised Southern hybridisation-based protocol that allows confident detection of the
presence of a C9ORF72 repeat expansion alongside independent assessment of its heterogeneity and the
number of repeat units. The protocol can be used with either a radiolabeled or non-radiolabeled probe. Using
this method we have successfully sized the C9ORF72 repeat expansion in lymphoblastoid cells, peripheral blood,
and post-mortem central nervous system (CNS) tissue from ALS patients. It was also possible to confidently
demonstrate the presence of repeat expansion, although of different magnitude, in both C9ORF72 alleles of the
genome of one patient.
Conclusions: The suggested protocol has sufficient advantages to warrant adoption as a standard for Southern
blot hybridisation analysis of GGGGCC repeat expansions in the C9ORF72 locus.
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Hexanucleotide repeat expansion in the C9ORF72 locus
has been identified as a genetic cause, or at least a strong
risk factor, for a significant proportion of amyotrophic
lateral sclerosis cases [1,2]. It is unknown whether the
expansion causes neuronal injury through a toxic gain of
function, haploinsufficiency or both mechanisms. Recent
studies suggested that not a protein encoded by the
ORF72 gene but dipeptide products of expanded repeat* Correspondence: buchmanvl@cf.ac.uk
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reproduction in any medium, provided the orregion translation might be toxic for neurons [3,4]. Gain
of function is consistent with apparently autosomal
dominant inheritance, parallels with other neurodegenera-
tive disorders caused by an intronic expansion [5], and the
suggestion of anticipation [6]. Difficulty in estimating the
size of the C9ORF72 expansion has precluded investiga-
tion of possible correlations between the repeat length and
disease characteristics such as age of onset, severity, or
speed of progression.
A repeat primed PCR technique quickly and reliably
determines whether a pathological C9ORF72 expansion
of >30 repeats is present in a DNA sample, [1,2] but does
not allow even approximate quantification of the repeat
number because the 100% GC content of the repeatral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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commonly used Southern hybridisation protocols for
detecting fragments encompassing the region of expansion
in the C9ORF72 locus often produce false-negative results
when DNA extracted from peripheral blood is analysed.
This is due to high repeat number heterogeneity in these
samples, which leads to the appearance of multiple high
molecular mass fragments forming a smear that might be
difficult to distinguish from non-specific binding of the
hybridisation probe to digested genomic DNA, even when
stringent hybridisation/washing conditions are employed
[7-9]. Here we describe a reproducible protocol for unam-
biguous detection and sizing of the C9ORF72 repeat
expansion by Southern hybridisation.Results and discussion
Our protocol produces an internal standard band on
Southern blots, the size and intensity of which is inde-
pendent of heterogeneity in the repeat expansion. This
is achieved by using as a hybridisation probe a cloned
genomic fragment encompassing an internal EcoRI site
located close to the repeat expansion region and digesting
genomic DNA with two enzymes, EcoRI and XbaI
(Figure 1A). The EcoRI site splits the probe into two
unequal fragments. Products of a labeling reaction origin-
ating from the shorter fragment of the probe hybridiseFigure 1 Southern blot analysis of GGGGCC repeat expansion in the C
human C9ORF72 gene with a single copy of GGGGCC sequence (top) or expa
probe used for Southern blot hybridisation. The sizes of fragments produced
this probe are shown. (B) Hybridisation of EcoRI and XbaI digested DNA extra
GGGGCC repeat expansion according to results of the repeat-PCR analysis. Th
below the image. Note that for sample 7 the intensity used for calculation is c
EcoRI and XbaI digested DNA extracted from the cultured lymphoblastoid cel
expansion according to results of the repeat-PCR analysis.with a 1.05 kb XbaI-EcoRI genomic fragment that does
not include the repeat region, while those originating from
the longer fragment (~2/3 of the probe length) hybridise
with a 1.33 kb XbaI-EcoRI fragment derived from a non-
expanded locus, or a larger fragment from a locus with
the repeat expansion (Figure 1A).Subjects without a pathological C9ORF72 hexanucleotide
expansion
Because the target XbaI-EcoRI fragments are quite similar
in size (thus, no effect of the transfer efficiency during
capillary blotting) but the ratio of probe length for
detecting each fragment is approximately 1:2, the ratio of
intensity of the two bands in the absence of an expanded
allele, should be approximately 1:2. Indeed DNA samples
from peripheral blood (Figure 1B, lanes 2, 4, 6) or
lymphoblastoid cell lines (Figure 1C, lanes 2, 23 and
Additional file 1: Table S1) from ALS patients without the
repeat expansion show this pattern.
A swing of the intensity ratio of the bands to approxi-
mately 1:1 is an indicator of heterozygosity in the C9ORF72
locus. If the difference in the number of repeats in the two
alleles is small (i.e. no pathological repeat expansion in
either allele) two close and equally weighted bands are
present on Southern blots even when whole blood cell
DNA is analysed, as illustrated in Figure 1B lane 7, using a9ORF72 locus. (A) Scheme of a region around exons 1a and 1b of
nsion of this repeat (bottom). The black bar in the middle denotes a DNA
by double EcoRI and XbaI digestion and detected by hybridisation with
cted from the whole blood of patients positive (+) or negative (−) for
e ratios of band intensities obtained by scanning the X-ray film are shown
ombined intensities of two close ~1.33 kb size bands. (C) Hybridisation of
l lines of patients positive (+) or negative (−) for GGGGCC repeat
Figure 2 Identification of a patient with GGGGCC repeat
expansion in both alleles of the C9ORF72 locus. Hybridisation of
EcoRI and XbaI digested DNA extracted from the cultured
lymphoblastoid cell lines of patients positive (+) or negative (−) for
GGGGCC repeat expansion according to results of the repeat-PCR
analysis. Note the presence of ~1.6 kb band representing an allele with
relatively small, although what is considered pathological, i.e. >30,
number of repeats in one of the C9ORF72 loci in the genome of three
patients (lanes 1 – 3). In contrast to patients carrying the second allele
without pathological repeat expansion (lanes 2–6), one patient (lane 1)
has the second allele with very high number of repeats. Where
relevant, the ratios of the 1.33 kb to 1.05 kb and/or ~1.6 kb to 1.05 kb
bands intensities are shown below the image. Note that for sample 6
the intensity used for calculation is combined intensities of two
close ~1.33 kb size bands.
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copy of the GGGGCC sequence and another allele with
15 copies.
Subjects with a pathological C9ORF72 hexanucleotide
expansion in one allele
In cases with a pathological repeat expansion in one allele,
a band of larger size is detected in DNA samples extracted
from patients’ lymphoblastoid cell lines. Examples of these
can be found in Figure 1C lanes 10 and 20 (~6 kb band cor-
responds to an allele with ~750 repeats), 15 (~7.5 kb band
corresponds to an allele with ~1000 repeats), 16 and 22
(~8.5 kb band corresponds to an allele with ~1200 repeats),
6 (~10 kb band corresponds to an allele with ~1500 re-
peats), 3, 7 and 13 (~12 kb band corresponds to an allele
with ~1800 repeats), 5, 8, 17 (>12 kb band corresponds to
an allele with >2000 repeats). For accuracy of size estimates
see Methods section. The presence in the sample of more
than one of these larger bands (for example, lanes 4, 8, 14,
18 in Figure 1C, lanes 4, 5 in Figure 2) might indicate in-
stability of the GGGGCC repeat region in the cultured
lymphoblastoid cells. Alternatively it might reflect instabil-
ity and somatic heterogeneity of the repeat region in ALS
patients’ lymphoid cells, coupled with non-monoclonal ori-
gin of the analysed lymphoblastoid cell lines. In whole
blood DNA such somatic heterogeneity is clearly evident in
some samples, leading to the appearance of multiple bands
that coalesce into an ambiguous smear on Southern blots
(Figure 1B, lanes 1, 5). For two other samples in the same
panel (Figure 1B, lanes 2, 6) lower quality of DNA caused
appearance of similar smears but the ratio of 1.05 kb and
1.33 kb band intensities in these cases are close to 1:2
suggesting that both alleles of the C9ORF72 locus have
small number of GGGGCC repeats. Therefore, even in
those cases with an ambiguous smear, the presence of a
pathological allele could be immediately predicted from
the ~1:1 ratio of 1.05 kb and 1.33 kb band intensities.
Subjects with a pathological C9ORF72 hexanucleotide
expansion in both alleles
The described protocol readily identifies patients with
repeat expansions within both C9ORF72 loci. These
cases are characterised by the absence of a 1.33 kb band
on Southern blots, as illustrated in Figure 2, lane 1 for a
patient carrying one allele with ~50 and another allele
with >2000 GGGGCC repeats in the C9ORF72 locus.
Southern hybridization in different tissues from the same
subject
When our Southern hybridisation protocol was used for
analysis of genomic DNA extracted from peripheral blood,
cerebellum, cortex and a lymphoblastoid cell line of pa-
tients with GGGGCC repeat expansion, a different pattern
of high molecular mass fragments has been detected foreach DNA sample of the same patient, as illustrated in
Figure 3 and Additional file 2: Figure S1. This observation
strongly suggests that an expanded repeat region in the
C9ORF72 locus is unstable not only in nucleated blood
cells but also in other somatic cells, including cells of the
central nervous system.
Although a 32P-radiolabeled hybridisation probe remains
the best option for detection of GGGGCC repeat expan-
sions in the C9ORF72 locus with the generation of clearer
and more quantitative results compared to those obtained
using DIG-labeled probes, in a pilot experiments we
Figure 3 Somatic cell genomes of ALS patients have variable
number of GGGGCC repeats in the C9ORF72 locus. Two sections
of the same Southern blot (see raw image in Additional file 2: Figure
S1) show hybridisation of EcoRI and XbaI digested DNA extracted
from peripheral blood, cerebellum and cerebral cortex of two
patients positive for GGGGCC repeat expansion. The ratios of the
1.33 kb to 1.05 kb bands intensities are shown below the image.
Note that in this case these ratios are unconventionally high, which
is due to the gel has been run for too long and therefore the
1.05 kb bands appeared too close to the edge of the gel, resulting
in less efficient transfer and hybridisation of this band. However, the
ratio for normal DNA sample is still approximately twice as high as
the ratio for all DNA samples with GGGGCC repeat expansion.
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protocol (data not shown).
Conclusions
Our optimised protocol for Southern hybridisation allows
simple and confident detection, as well as sizing of the re-
peat expansion in various types of cells and tissues. Thus
we recommend this protocol as an acceptable standard for
Southern blot hybridisation analysis of GGGGCC repeat
expansions in the C9ORF72 locus.
Methods
DNA extraction
Whole blood samples were obtained from the Sheffield
MND Blood DNA Biobank and CNS tissue was
obtained from the Sheffield Brain Tissue Bank. The
South Sheffield Research Ethics Committee approved
the study, and informed consent was obtained for allsamples. Lymphoblastoid cell lines were obtained from
patients with ALS from the Wellcome Trust/Motor
Neurone Disease Association-funded ALS/MND DNA
bank and associated lymphoblastoid cell line repository
in the UK.
Before lysis with a digest buffer (50 mM Tris–HCl
pH 8.0; 100 mM NaCl; 5 mM EDTA; 1% SDS; 2 mg/ml
proteinase K) frozen CNS tissues were grinded in liquid
nitrogen. Following overnight digestion at 55°C genomic
DNA was extracted twice with phenol and once with
phenol/chloroform and ethanol precipitated.
Southern hybridisation
A genomic fragment was amplified from a human DNA
using oligonucleotide primers AGTTCCAGAGCTTG
CTACAG and GAACAGTAGGAAAAGGGTCTG and
cloned into the pCR-BluntII-TOPO vector (Invitrogen) to
produce a pCh9.1 plasmid carrying an insert used as the
hybridisation probe (Additional file 3: Figure S2). Well-
established and widely used methods of Southern transfer,
preparation of the probe and hybridisation procedure were
used. In brief, approximately 20 μg of genomic DNA was
digested with EcoRI and XbaI and the resulting fragments
separated in 1% TAE agarose gel. After incubating the gel
in 0.25 N HCl for 20 min, 0.5 N NaOH; 1.5 M NaCl for
40 min and 0.5 M Tris–HCl pH7.2; 3 M NaCl for 40 min
at room temperature, DNA was transferred to a nylon
membrane (Hybond N+, GE Healthcare) by capillary blot-
ting [10]. An eukaryotic insert of the plasmid pCh9.1 was
excised using KpnI and XbaI, separated from the plasmid
backbone in agarose gel, purified using Qiagen kit and
used for preparing hybridisation probes. The probe was la-
belled with 32P in a nick-translation reaction [11]. Blots
were prehybridised in HB (4×SSC; 0.5% SDS; 5×Denhardt’s
solution; 100 μg/ml denatured salmon testis DNA) at 67°C
for 4 h. Labelled DNA was denatured by incubation at
100°C for 5 min followed by immediate mixing with ice–
cold HB. Hybridisation was carried out at 67°C for 16–
20 h. Blots were washed 3 times in in 2×SSC; 0.2% SDS at
67°C and exposed to X-ray film. The detailed protocol as
well as the pCh9.1 plasmid carrying an insert used as the
hybridisation probe can be obtained by sending a request
to Vladimir Buchman (buchmanvl@cf.ac.uk).
DNA extracted from 32 lymphoblastoid cell lines
obtained from the MND National Biobank was used for
Southern hybridisation analysis. This included 29 cases
with a C9ORF72 expansion identified by repeat-PCR and
3 cases with non-C9ORF72 ALS. For certain cases DNA
was also extracted from peripheral blood and CNS tissue
available from the Sheffield Brain Tissue and DNA bank.
Quantification of the band intensity ratios
When at least one normal (without repeat expansion)
DNA sample is present on the blot as a reference, the
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in this sample and in samples with repeat expansion can
be easily recognised by eye. However, this difference can
be quantified by scanning X-ray films, measuring bands
using a software available for every gel documentation sys-
tem and calculating the ratio of pixels in 1.33 kb and 1.05
bands for each sample. Even when for any technical
reasons, the ratio of bands in samples with repeat expan-
sion is higher than conventional 1:1, this is accompanied
by corresponding increase of the ratio in a normal sample
(s) present on the same Southern blot, which still allows
discrimination of repeat-bearing and normal cases by eye.
An example of this is shown in Figure 3.
Estimation of the number of repeats within an expanded
allele
The number of repeats within the expanded allele is esti-
mated based on the size of corresponding fragment in base
pairs minus the size of the non-expanded fragment (1330
base pairs) and divided by the size of the repeat unit (6 base
pairs). For example, if the size of a fragment was 3 kb, esti-
mated number of repeats in the corresponding locus is
(3000 – 1330)/6 = 278. As with any method based on agar-
ose gel electrophoresis, an accuracy of the repeat number
estimate using the described protocol varies with the size
of detected fragments. In the range of the repeat-bearing
fragment size between 1.5 kb (which corresponds to an
upper limit for a “normal” allele, i.e. less than 30 repeats =
0.18 kb + 1.33 kb -> 1.51 kb) and 3 kb (~300 repeats) the
accuracy of the estimate might be around 10 repeats;
between 3 kb and 6 kb (~750 repeats) it drops to ~50
repeats and between 6 kb and 10 kb (~1500 repeats) – to
200 repeats. Any bands above 12 kb should be considered
as >2000 repeats.
Additional files
Additional file 1: Table S1. Ratios of 1.33 kb and 1.05 kb bands
intensities for samples shown in Figure 1C.
Additional file 2: Figure S1. Raw image of the Southern blot used for
preparing main Figure 3.
Additional file 3: Figure S2. Scheme of a DNA fragment used as a
hybridisation probe inserted into a polylinker cloning site of pCR-Blunt
II-TOPO plasmid. The sequence of the plasmid polylinker region is from
the Invitrogen manual for TOPO cloning kit.
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